Found: 299
Select item for more details and to access through your institution.
ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cardiac Conduction Disorders as Markers of Cardiac Events in Myotonic Dystrophy Type 1.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2455, doi. 10.1007/s00432-021-03784-3
- By:
- Publication type:
- Article
Characterization of tumour mutation burden in patients with non‐small cell lung cancer and interstitial lung disease.
- Published in:
- Respirology, 2020, v. 25, n. 8, p. 850, doi. 10.1111/resp.13726
- By:
- Publication type:
- Article
Waldenström macroglobulinemia diagnosed by bronchoalveolar lavage.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 8, p. 738, doi. 10.1093/jjco/hyad047
- By:
- Publication type:
- Article
Survival outcome of upfront surgery for clinical single-station N2 non-small cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 5, p. 429, doi. 10.1093/jjco/hyac209
- By:
- Publication type:
- Article
Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1736, doi. 10.1093/jjco/hyab158
- By:
- Publication type:
- Article
A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1914
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 836, doi. 10.1093/jjco/hyab025
- By:
- Publication type:
- Article
Pembrolizumab-related sclerosing cholangitis manifested by a pruned-tree appearance of the bile ducts.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 4, p. 666, doi. 10.1093/jjco/hyaa201
- By:
- Publication type:
- Article
Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157
- By:
- Publication type:
- Article
PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 5, p. 617, doi. 10.1093/jjco/hyaa033
- By:
- Publication type:
- Article
Radiotherapy for local recurrence of non-small-cell lung cancer after lobectomy and lymph node dissection—can local recurrence be radically cured by radiation?
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 4, p. 425, doi. 10.1093/jjco/hyz188
- By:
- Publication type:
- Article
Osimertinib for patients with EGFR T790M mutation-positive non–small-cell lung cancer and a poor performance status.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 7, p. 671, doi. 10.1093/jjco/hyz041
- By:
- Publication type:
- Article
A Phase II study of palonosetron, aprepitant, dexamethasone and olanzapine for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in patients with thoracic malignancy.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 9, p. 840, doi. 10.1093/jjco/hyx084
- By:
- Publication type:
- Article
Implementation status and explanatory analysis of early advance care planning for Stage IV non-small cell lung cancer patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 3, p. 261, doi. 10.1093/jjco/hyu207
- By:
- Publication type:
- Article
A Feasibility Study of Carboplatin Plus Irinotecan Treatment for Elderly Patients with Extensive Disease Small-cell Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 2, p. 116, doi. 10.1093/jjco/hyt195
- By:
- Publication type:
- Article
FLAIR hyperintensity along the brainstem surface in leptomeningeal metastases: a case series and literature review.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The outcome of closure of inguinal hernia with laparoscopic percutaneous extraperitoneal closure in young adults.
- Published in:
- World Journal of Surgery, 2024, v. 48, n. 2, p. 371, doi. 10.1002/wjs.12022
- By:
- Publication type:
- Article
Retroperitoneoscopic Nephrectomy/Heminephrectomy in Children Planned, Performed, and Managed by Supervised Senior Pediatric Surgical Trainees.
- Published in:
- Journal of Laparoendoscopic & Advanced Surgical Techniques, 2013, v. 23, n. 8, p. 723, doi. 10.1089/lap.2013.0135
- By:
- Publication type:
- Article
Open Versus Laparoscopic Treatment for Pan-Peritonitis Secondary to Perforated Appendicitis in Children: A Prospective Analysis.
- Published in:
- Journal of Laparoendoscopic & Advanced Surgical Techniques, 2010, v. 20, n. 7, p. 655, doi. 10.1089/lap.2010.0079
- By:
- Publication type:
- Article
Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma.
- Published in:
- International Journal of Hematology, 2015, v. 101, n. 1, p. 46, doi. 10.1007/s12185-014-1694-8
- By:
- Publication type:
- Article
Multicenter questionnaire survey for sporadic inclusion body myositis in Japan.
- Published in:
- Orphanet Journal of Rare Diseases, 2016, v. 11, p. 1, doi. 10.1186/s13023-016-0524-x
- By:
- Publication type:
- Article
Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Remarkable Alteration of PD-L1 Expression after Immune Checkpoint Therapy in Patients with Non-Small-Cell Lung Cancer: Two Autopsy Case Reports.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 2, p. 1633, doi. 10.1007/s00520-021-06572-4
- By:
- Publication type:
- Article
Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512)
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 5, p. 2327, doi. 10.1007/s00520-020-05765-7
- By:
- Publication type:
- Article
Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 6, p. 1699, doi. 10.1007/s00520-014-2534-3
- By:
- Publication type:
- Article
Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor–Positive Non‐Small Cell Lung Cancer.
- Published in:
- Cancer Reports, 2024, v. 7, n. 9, p. 1, doi. 10.1002/cnr2.70004
- By:
- Publication type:
- Article
Continuous feeding via gastrostomy in short bowel syndrome.
- Published in:
- Pediatrics International, 2021, v. 63, n. 5, p. 590, doi. 10.1111/ped.14443
- By:
- Publication type:
- Article
ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-29397-z
- By:
- Publication type:
- Article
Exome sequencing identifies a novel TTN mutation in a family with hereditary myopathy with early respiratory failure.
- Published in:
- Journal of Human Genetics, 2013, v. 58, n. 5, p. 259, doi. 10.1038/jhg.2013.9
- By:
- Publication type:
- Article
Catheter failure in the administration of hyperosmotic drugs through a peripheral vein and vascular selection: A retrospective cohort study.
- Published in:
- Drug Discoveries & Therapeutics, 2021, v. 15, n. 5, p. 236, doi. 10.5582/ddt.2021.01080
- By:
- Publication type:
- Article
Development of an algorithm using ultrasonography-assisted peripheral intravenous catheter placement for reducing catheter failure.
- Published in:
- Drug Discoveries & Therapeutics, 2020, v. 14, n. 1, p. 27, doi. 10.5582/ddt.2019.01094
- By:
- Publication type:
- Article
Catheter tips are a possible resource for biological study on catheter failure.
- Published in:
- Drug Discoveries & Therapeutics, 2019, v. 13, n. 5, p. 280, doi. 10.5582/ddt.2019.01073
- By:
- Publication type:
- Article
Exploring the causes of peripheral intravenous catheter failure based on shape of catheters removed from various insertion sites.
- Published in:
- Drug Discoveries & Therapeutics, 2018, v. 12, n. 3, p. 170, doi. 10.5582/ddt.2018.01024
- By:
- Publication type:
- Article
Low-temperature infiltration identified using infrared thermography in patients with subcutaneous edema revealed ultrasonographically: A case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
The relationship between the tip position of an indwelling venous catheter and the subcutaneous edema.
- Published in:
- BioScience Trends, 2015, v. 9, n. 6, p. 414, doi. 10.5582/bst.2015.01114
- By:
- Publication type:
- Article
Biomechanical study of optimum anchorage in dome-shaped high tibial osteotomy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Thenar muscle metastasis as recurrence of pulmonary squamous cell carcinoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, n. 1, p. 15, doi. 10.1111/j.1743-7563.2010.01373.x
- By:
- Publication type:
- Article
Clinical pharmacological profile of etoposide in elderly patients with lung cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2005, v. 1, n. 2/3, p. 92, doi. 10.1111/j.1743-7563.2005.00011.x
- By:
- Publication type:
- Article
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 2, p. 356, doi. 10.1007/s10637-023-01353-8
- By:
- Publication type:
- Article
Correction to: Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non‑small cell lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 403, doi. 10.1007/s10637-021-01191-6
- By:
- Publication type:
- Article
Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 106, doi. 10.1007/s10637-021-01155-w
- By:
- Publication type:
- Article
Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1732, doi. 10.1007/s10637-021-01140-3
- By:
- Publication type:
- Article
Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1716, doi. 10.1007/s10637-021-01136-z
- By:
- Publication type:
- Article
Correction to: Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 571, doi. 10.1007/s10637-020-01005-1
- By:
- Publication type:
- Article
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1854, doi. 10.1007/s10637-020-00943-0
- By:
- Publication type:
- Article